1. Guest, the 'News in Brief' for the week beginning 23rd November 2020 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Guest, NICE have published their draft guideline for ME/CFS, click here to read about it.
    Dismiss Notice

ampligen

  1. Andy
    Thread

    Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for [ME/CFS], 2020, Mitchell et al

    Rintatolimod = Ampligen A hypothesis-based post-hoc analysis of the Intent to Treat (ITT) population diagnosed with ME/CFS from 12 independent...
    Thread by: Andy, Oct 30, 2020, 16 replies, in forum: BioMedical ME/CFS Research
  2. Sly Saint
    Thread

    A Controlled Clinical Trial with a Specifically Configured RNA Drug, Poly(I). POly(C12U), in Chronic Fatigue Syndrome - 1994 Strayer, Cheney et al

    Clinical Infectious Diseases, Volume 18, Issue Supplement_1, January 1994, Pages S88–S95, https://doi.org/10.1093/clinids/18.Supplement_1.S88...
    Thread by: Sly Saint, Feb 29, 2020, 1 replies, in forum: BioMedical ME/CFS Research
  3. rvallee
    Thread

    Discussion of documentary: What about ME? (2016)

    Two days ago I was made aware of a documentary titled "What about ME?", published in 2016. First time I had heard of it and maybe I missed...
    Thread by: rvallee, Dec 16, 2019, 2 replies, in forum: General Advocacy Discussions
  4. Sly Saint
    Thread

    Simmaron Research fundraising for clinical research including Ampligen

    [MEDIA]
    Thread by: Sly Saint, Apr 24, 2019, 0 replies, in forum: Fundraising
  5. Sly Saint
    Thread

    Hemispherx to Present at the 8th Annual LD Micro Invitational

    "ORLANDO, Fla., May 10, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced today that it will be presenting at the...
    Thread by: Sly Saint, May 10, 2018, 0 replies, in forum: BioMedical ME/CFS News
  6. Sly Saint
    Thread

    Ampligen - Hemispherx Biopharma re ME/CFS

    "PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third...
    Thread by: Sly Saint, Nov 24, 2017, 66 replies, in forum: BioMedical ME/CFS News
Showing results 1 to 6 of 6